Hasnain Faheem
- SEC CIK
- 0001352620
In the past year, 1 open-market sale filing worth $109.8K and no purchases.
Current role at each company
- GOSS Gossamer Bio, Inc.President & CEOas of Aug 26, 2026
- KURA Kura Oncology, Inc.Directoras of Jun 4, 2026
- MRTX Mirati Therapeutics, Inc.Directoras of Jan 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $109.8K
- 1 filing
- Net
- −$109.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hasnain Faheem as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KURA Kura Oncology, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 (view filing) | Dec 9 | 1 day | Hasnain FaheemDirector | SSale | −10.0K | $10.98 | −$109.8K | −29.4%24.0K after | |
| Mar 24, 2025 (view filing) | Mar 21 | 3 days | Hasnain FaheemDirector | SSale | −22.7K | $8.00 | −$181.5K | −48.6%24.0K after |
GOSS Gossamer Bio, Inc.
President & CEO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 (view filing) | Jun 21 | 3 days | Hasnain FaheemPresident & CEO | PPurchase | +372.0K | $0.67 | +$249.2K | +7.4%5.41M after | |
| Mar 28, 2024 (view filing) | Mar 27 | 1 day | Hasnain FaheemPresident & CEO | SSale | −23.2K | $1.16 | −$26.9K | −16.2%120.3K after | |
| Mar 22, 2023 (view filing) | Mar 20-22 | 2 days | Hasnain FaheemPresident & CEO | PPurchase | +878.6K | $1.14 | +$999.2K | +24.3%4.50M after | 3 lots |
| Jul 15, 2022 (view filing) | Jul 15 | Same day | Hasnain FaheemPresident & CEO | PPurchase | +138.7K | $7.21 | +$1.00M | +4.0%3.62M after | |
| Mar 24, 2022 (view filing) | Mar 23 | 1 day | Hasnain FaheemPresident & CEO | SSale | −19.0K | $8.92 | −$169.8K | −11.7%143.5K after |
MRTX Mirati Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Hasnain FaheemDirector | PPurchase | +10.8K | $27.80 | +$300.0K | New position10.8K after |